Prof. Erich Seifritz, MD, Director, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich
Prof. Dr. Boris Quednow, Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zurich
Prof. Birgit Kleim, PhD, Division of Clinical Psychology and Psychotherapy, University Hospital of Psychiatry Zurich
Prof. Hanspeter Landolt, PhD, Institute of Pharmacology and Toxicology, University of Zurich
Prof. Thomas Krämer, Forensic Pharmacology and Toxicology, University of Zurich
PD Felix Scholkmann, PhD, Biomedical Optics Research Laboratory, University Hospital Zurich
PD Kurt Stocker, PhD, Project Leader Consciousness Studies, Chair of Cognitive Science, ETH Zurich
Prof. Paul Cumming, PhD, Department of Nuclear Medicine, University Hospital of Bern
Prof. Andrew Gloster, PhD, Clinical Psychology and Intervention Science, Faculty of Psychology, University of Basel
Prof. Michael Ashton, PhD, Department of Pharmacology, University of Gothenburg, Sweden
PD Maxim Puchkov, PhD, Department of Pharmaceutical Sciences, University of Basel
Davor Kosanic, PhD, Innovation Projects, EPFL
Daniel Claussen, MBA, CBO, Reconnect Labs AG
Michael Kometer, PhD, Co-Founder & Managing Director, Neuronomics AG
David Andel, Co-Founder & CTO, Neuronomics AG
Ansgar Rougemont-Bücking, MD, Department of Neurosciences and Movement Science, Faculty of Science and Medicine, University of Fribourg
Heiner Dörfler, MD, Praxis für Humanistische Psychotherapie, Zürich
Philipp Horstmann, MD, resident physician, Psychiatric University Hospital Zurich
John Smallridge, MSci, Msc, Founder & Managing Director, Neuronaut Ltd
Michael J. Müller, PhD, Advisor & Lab Assist, ETH Zürich
